HIV-Tat dependent chemotaxis and invasion, key aspects of Tat mediated pathogenesis

Clinical and Experimental Metastasis

Volumn 18, Issue 7, 2000, Pages 533-538

  Vene R ^a   Benelli, R ^a   Noonan, D M ^b   Albini, A ^b  

^a Advanced Biotechnology Center   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Chemokine; Chemotaxis; HIV; Tat; VEGF

Indexed keywords

AMINO ACID; ANGIOGENIC FACTOR; CALCIUM ION; CHEMOATTRACTANT; CHEMOKINE; TRANSACTIVATOR PROTEIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; B LYMPHOCYTE; CALCIUM MOBILIZATION; CANCER CELL; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL INVASION; CELL MIGRATION; CHEMOTAXIS; DENDRITIC CELL; ENDOTHELIUM CELL; HELPER CELL; HUMAN; HUMAN CELL; KAPOSI SARCOMA; METASTASIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CHEMOTAXIS; GENE PRODUCTS, TAT; HIV INFECTIONS; HUMANS; LIGANDS; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; SARCOMA, KAPOSI;

EID: 0034788234     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011991906685     Document Type: Review

References (64)

1. Tat as a transcriptional activator and a potential therapeutic target for HIV-1
2. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes
3. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells
4. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein
5. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines
6. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure
7. HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line
8. Repression of MHC class I gene promoter activity by two-exon Tat of HIV
9. Activation of expression of genes coding for extracellular matrix protein in Tat-producing glioblastoma cells
10. A novel approach to protein-protein interaction: Complex formation between the p53 tumor suppressor and the HIV Tat proteins
11. Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat
12. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat
13. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation
14. Cellular uptake of the tat protein from human immunodeficiency virus
15. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence
16. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1
17. The angiogenesis induced by HIV-1 Tat is mediated by the flk-1/KDR receptor on vascular endothelial cells
18. HIV-1 Tat protein mimicry of chemokines
19. Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
20. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): A possible mechanism for Tat's immunosuppressive activity
21. From the outside in: Extracellular activities of HIV Tat
22. The HIV tat gene transforms human keratinocytes
23. Systemic expression of HIV 1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes
24. Promotion of tumor metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice
25. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma
26. Angiogenic potential in vivo by Kaposi sarcoma cell-free supernatants and HIV 1-tat product: Inhibition of KS-like lesions by TIMP-2
27. Angiogenic properties of human immunodeficiency virus type 1 Tat protein
28. Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma
29. HIV-tat protein is a heparin-binding angiogenic growth factor
30. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells
31. Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells
32. Kaposi's sarcoma cells of different etiologic origins respond to HIV- Tat through the Flk-1/KDR (VEGFR-2): Relevance in AIDS-KS pathology
33. HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment
34. Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with erbB-2 in human carcinoma cell lines
35. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
36. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the α5β1 and αvβ3 integrins and by mobilizing sequestered basic fibroblast growth factor
37. Motility induced by human immunodeficiency virus-1 tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis
38. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat
39. Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides
40. The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by Dendritic cells
41. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis
42. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes
43. Identifcation of a novel domain of HIV Tat involved in monocyte chemotaxis
44. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death
45. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors
46. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes
47. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes
48. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat
49. Selective CXCR4 antagonism by tat: Implications for in vivo expansion of coreceptor use by HIV-1
50. Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: Implications for Tat-mediated pathogenesis
51. The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice
52. Tat protein is an HIV-1-encoded β-chemokine homolog that promotes migration and up-regulates CCR3 expression on human FcεR1(+) cells
53. Molecular pathway involved in HIV-1-induced CNS pathology: Role of viral regulatory protein, Tat
54. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: Involvement of cytokines
55. Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia
56. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice
57. Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cells
58. HIV-induced T-cell syncytia release a two component T-helper cell chemoattractant composed of Nef and Tat
59. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: Implications for AIDS-Kaposi's sarcoma pathogenesis
60. Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice
61. Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB
62. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors
63. Structural studies of HIV-1 Tat protein
64. Secretion of mammalian proteins that lack a signal sequence